Podofilox 0.5% Gel 3.5gm
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. It is essential to use this medication as directed.
Application Instructions
Apply this medication only to your skin, as directed by your doctor. Do not ingest it.
Avoid getting the medication in your mouth, nose, or eyes, as it may cause burning. If accidental contact occurs, flush the affected area with cool water immediately and seek medical attention.
Wash your hands thoroughly before and after applying the medication.
Apply a thin layer of the medication to the affected skin area, as instructed by your doctor. Be sure to only apply it to the warts and avoid putting it on healthy skin.
Allow the treated skin to dry completely before touching untreated skin.
Important Safety Precautions
This medication is flammable, so avoid using it near an open flame or while smoking.
Storage and Disposal
Store the medication at room temperature, away from heat and open flames. Do not freeze.
Keep the lid tightly closed when not in use.
Missed Dose Instructions
If you miss a dose, apply it as soon as you remember.
If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular application schedule.
* Do not apply two doses at the same time or use extra doses to make up for a missed dose.
Lifestyle & Tips
- Wash hands thoroughly before and after applying the gel.
- Apply only to the warts, avoiding healthy skin. If gel gets on healthy skin, wash it off immediately.
- Do not apply to bleeding, irritated, or open skin.
- Avoid contact with eyes. If contact occurs, flush eyes thoroughly with water and seek medical attention.
- Do not use internal warts (e.g., inside the vagina, anus, or urethra).
- Allow the gel to dry completely before clothing comes into contact with the treated area.
- Follow the dosing schedule precisely: 3 days on, 4 days off. Do not apply more often or for longer than prescribed.
- Sexual activity should be avoided while the gel is on the skin. Condoms may not fully protect partners from exposure to the medication or HPV.
- This medication does not cure HPV and does not prevent the spread of HPV.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Bleeding at the site where the medication is administered
Swelling at the site where the medication is administered
Other Possible Side Effects
Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, or if they persist or bother you, contact your doctor:
Headache
* Skin reactions at the site where the medication is administered, such as:
+ Burning or stinging
+ Itching
+ Pain
+ Redness
If you experience severe skin reactions or those that persist or bother you, contact your doctor for guidance.
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, contact your doctor for medical advice. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe burning, stinging, pain, or swelling at the application site.
- Bleeding or ulceration of the treated area.
- Signs of systemic absorption (rare, but serious): nausea, vomiting, abdominal pain, diarrhea, dizziness, confusion, numbness or tingling in hands/feet.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) medications, natural products, and vitamins. This information will help your doctor assess potential interactions between this medication and other substances.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that this medication can be taken with all your current medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Adhere to your doctor's prescribed treatment duration and do not use this medication for an extended period beyond the recommended timeframe. If your symptoms do not improve or worsen within 4 weeks, consult your doctor to reassess your treatment plan.
Note that this medication does not prevent the spread of warts to others. Discuss with your doctor the necessary precautions to prevent the transmission of genital warts. Additionally, talk to your doctor about the appropriate use of birth control methods to prevent pregnancy while taking this medication. If you become pregnant, notify your doctor immediately.
Before starting treatment, inform your doctor if you are pregnant, planning to become pregnant, or are breast-feeding. This will enable a discussion about the potential benefits and risks of the medication to both you and your baby, allowing for an informed decision about your treatment.
Overdose Information
Overdose Symptoms:
- Severe local reactions (pain, burning, ulceration)
- Systemic toxicity (if ingested or applied to large areas/broken skin): nausea, vomiting, diarrhea, abdominal pain, fever, lethargy, dizziness, confusion, headache, paresthesias, peripheral neuropathy, bone marrow suppression (leukopenia, thrombocytopenia), liver and kidney dysfunction, coma, seizures.
What to Do:
Immediately wash the treated area with soap and water. If ingested, seek emergency medical attention or call a Poison Control Center (1-800-222-1222) immediately. Treatment is supportive. There is no specific antidote.
Drug Interactions
Monitoring
Baseline Monitoring
Rationale: To assess size, number, and location of warts before initiating treatment.
Timing: Prior to first application
Routine Monitoring
Frequency: Before each new treatment cycle (e.g., weekly)
Target: Reduction in wart size/number, absence of new lesions
Action Threshold: If irritation or inflammation occurs, temporarily discontinue treatment. If warts persist after 4 cycles, consider alternative therapies.
Frequency: Daily during treatment days
Target: Mild to moderate reactions are common and expected. Severe reactions should prompt discontinuation.
Action Threshold: Severe pain, burning, swelling, or ulceration; discontinue treatment and seek medical advice.
Symptom Monitoring
- Local irritation (burning, stinging, redness, soreness)
- Pain at application site
- Inflammation
- Erosion or ulceration of skin
- Bleeding
- Itching
- Systemic symptoms (rare, but indicate excessive absorption): nausea, vomiting, abdominal pain, diarrhea, dizziness, confusion, peripheral neuropathy, bone marrow suppression (in cases of severe overdose/misuse)
Special Patient Groups
Pregnancy
CONTRAINDICATED in pregnancy (Pregnancy Category X). Podofilox can cause fetal harm when administered to a pregnant woman. It is embryotoxic and teratogenic in animals. Women of childbearing potential should be advised to use effective contraception during treatment.
Trimester-Specific Risks:
Lactation
Use is generally not recommended during breastfeeding (Lactation Risk L3 - Moderately Safe). It is unknown whether podofilox is excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and efficacy have not been established in pediatric patients under 18 years of age. Use is generally not recommended.
Geriatric Use
No specific dose adjustments are required for geriatric patients. However, caution should be exercised due to potentially thinner skin and increased susceptibility to local irritation. Systemic absorption is minimal, so age-related changes in renal or hepatic function are unlikely to significantly impact drug clearance.
Clinical Information
Clinical Pearls
- Podofilox is for external use only. It should not be used on mucous membranes (e.g., inside the mouth, nose, vagina, anus, or urethra).
- Patients should be instructed on the correct application technique to minimize exposure to healthy skin and prevent systemic absorption.
- The treatment cycle (3 days on, 4 days off) is crucial for efficacy and to allow for recovery of healthy skin.
- Local irritation (burning, redness, soreness) is common and usually mild to moderate. Patients should be advised that this is an expected part of the treatment.
- If warts do not respond after 4 cycles, alternative treatment modalities should be considered.
- Podofilox does not prevent the transmission of HPV or other sexually transmitted infections.
Alternative Therapies
- Imiquimod cream (Aldara, Zyclara)
- Sinecatechins ointment (Veregen)
- Cryotherapy (liquid nitrogen)
- Trichloroacetic acid (TCA) or Bichloroacetic acid (BCA)
- Surgical excision
- Electrocautery
- Laser therapy